SEC Form 4 · accession 0001127602-16-048046
LABCORP HOLDINGS INC. · LH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T. Boyle Jr.
Officer — EVP,CEO of LabCorp Diagnostics
Period of report
Mar 30, 2016
Accepted (ET)
Apr 1, 2016 · 1:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920148
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2016 | A | 34,737 | $0.00 | A | 58,191 | D | |
| Common Stock | Mar 30, 2016 | F | 16,605 | $117.85 | D | 41,586 | D | |
| Common StockF4 | Mar 31, 2016 | S | 13,191 | $116.67 | D | 28,395 | D | |
| Common StockF5 | Mar 31, 2016 | S | 4,941 | $117.19 | D | 23,454 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired on March 30, 2016, pursuant to a performance award granted on February 12, 2013, relating to performance during the three-year period ended December 31, 2015.
- F2Stock withholding to satisfy tax withholding obligations.
- F3Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F4The price of $116.67 per share represents a weighted average of sales prices ranging from $116.10 to $117.09 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F5The price of $117.19 per share represents a weighted average of sales prices ranging from $117.10 to $117.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.